Concepts (167)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 2 | 20 | 2024 | 1237 | 2.140 |
Why?
|
| Diabetes Mellitus, Type 1 | 9 | 2024 | 798 | 1.000 |
Why?
|
| Hypoglycemic Agents | 12 | 2022 | 429 | 0.980 |
Why?
|
| Insulin Resistance | 5 | 2021 | 644 | 0.860 |
Why?
|
| Metformin | 4 | 2020 | 147 | 0.710 |
Why?
|
| Blood Glucose | 15 | 2024 | 1123 | 0.700 |
Why?
|
| Hyperglycemia | 4 | 2022 | 222 | 0.630 |
Why?
|
| Hypoglycemia | 4 | 2022 | 191 | 0.630 |
Why?
|
| Health Services Accessibility | 1 | 2020 | 595 | 0.490 |
Why?
|
| Insulin | 7 | 2022 | 1208 | 0.440 |
Why?
|
| Adolescent | 24 | 2024 | 19127 | 0.350 |
Why?
|
| Medication Adherence | 3 | 2020 | 389 | 0.280 |
Why?
|
| Evidence-Based Medicine | 1 | 2011 | 623 | 0.280 |
Why?
|
| Peer Group | 1 | 2024 | 119 | 0.220 |
Why?
|
| Mentors | 1 | 2024 | 143 | 0.210 |
Why?
|
| Quality of Life | 3 | 2024 | 1933 | 0.200 |
Why?
|
| Transition to Adult Care | 1 | 2024 | 119 | 0.200 |
Why?
|
| Circadian Rhythm | 1 | 2024 | 269 | 0.190 |
Why?
|
| Puberty | 1 | 2021 | 94 | 0.180 |
Why?
|
| Sleep | 1 | 2024 | 350 | 0.180 |
Why?
|
| Self Report | 1 | 2024 | 517 | 0.180 |
Why?
|
| Wearable Electronic Devices | 1 | 2022 | 100 | 0.180 |
Why?
|
| Child | 18 | 2022 | 24256 | 0.170 |
Why?
|
| Humans | 32 | 2024 | 123259 | 0.170 |
Why?
|
| Insurance Coverage | 1 | 2020 | 121 | 0.160 |
Why?
|
| Vulnerable Populations | 1 | 2020 | 140 | 0.160 |
Why?
|
| Age of Onset | 1 | 2020 | 581 | 0.160 |
Why?
|
| Menstruation Disturbances | 1 | 2018 | 13 | 0.150 |
Why?
|
| Medicaid | 1 | 2020 | 244 | 0.150 |
Why?
|
| Self Care | 3 | 2024 | 213 | 0.140 |
Why?
|
| Young Adult | 5 | 2024 | 8867 | 0.140 |
Why?
|
| Diabetic Nephropathies | 1 | 2017 | 111 | 0.130 |
Why?
|
| Cohort Studies | 3 | 2020 | 4701 | 0.130 |
Why?
|
| Nutrition Surveys | 1 | 2017 | 290 | 0.130 |
Why?
|
| Insulin Infusion Systems | 3 | 2022 | 61 | 0.130 |
Why?
|
| Glucagon | 1 | 2016 | 185 | 0.130 |
Why?
|
| Gastrointestinal Agents | 1 | 2016 | 60 | 0.120 |
Why?
|
| Male | 19 | 2024 | 60333 | 0.120 |
Why?
|
| Female | 20 | 2024 | 65615 | 0.120 |
Why?
|
| Depression | 4 | 2016 | 1230 | 0.120 |
Why?
|
| Biomarkers | 2 | 2024 | 2953 | 0.120 |
Why?
|
| Family | 2 | 2009 | 567 | 0.110 |
Why?
|
| Diabetes Mellitus | 1 | 2022 | 850 | 0.110 |
Why?
|
| Diabetic Cardiomyopathies | 1 | 2014 | 15 | 0.110 |
Why?
|
| Risk Factors | 6 | 2024 | 10035 | 0.110 |
Why?
|
| Diabetic Angiopathies | 1 | 2014 | 61 | 0.110 |
Why?
|
| Adult | 7 | 2024 | 29098 | 0.100 |
Why?
|
| Metabolic Syndrome | 1 | 2015 | 329 | 0.100 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2009 | 805 | 0.090 |
Why?
|
| Heart Atria | 1 | 2014 | 313 | 0.090 |
Why?
|
| Blood Glucose Self-Monitoring | 2 | 2023 | 113 | 0.090 |
Why?
|
| Body Mass Index | 4 | 2021 | 1553 | 0.090 |
Why?
|
| Cysteine | 1 | 2010 | 134 | 0.080 |
Why?
|
| Glycine | 1 | 2010 | 169 | 0.080 |
Why?
|
| Autoantibodies | 2 | 2023 | 426 | 0.080 |
Why?
|
| Glutathione | 1 | 2010 | 195 | 0.080 |
Why?
|
| Heart Ventricles | 1 | 2014 | 763 | 0.080 |
Why?
|
| Pilot Projects | 2 | 2020 | 1389 | 0.080 |
Why?
|
| Glucose | 2 | 2023 | 880 | 0.070 |
Why?
|
| Obesity, Morbid | 1 | 2010 | 186 | 0.070 |
Why?
|
| Parents | 1 | 2015 | 1032 | 0.070 |
Why?
|
| Obesity | 3 | 2015 | 2235 | 0.070 |
Why?
|
| United States | 2 | 2020 | 10652 | 0.070 |
Why?
|
| Patient Compliance | 1 | 2011 | 469 | 0.070 |
Why?
|
| Cardiovascular Diseases | 3 | 2015 | 1877 | 0.070 |
Why?
|
| Urban Health Services | 1 | 2007 | 22 | 0.070 |
Why?
|
| Parent-Child Relations | 1 | 2009 | 250 | 0.070 |
Why?
|
| Pregnancy, Multiple | 1 | 2006 | 50 | 0.070 |
Why?
|
| Magnesium Sulfate | 1 | 2006 | 50 | 0.070 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2006 | 54 | 0.070 |
Why?
|
| Health Promotion | 1 | 2007 | 390 | 0.060 |
Why?
|
| Health Behavior | 1 | 2007 | 382 | 0.060 |
Why?
|
| Social Support | 1 | 2005 | 344 | 0.050 |
Why?
|
| Insulin, Regular, Human | 1 | 2022 | 11 | 0.050 |
Why?
|
| Diabetes Complications | 1 | 2024 | 196 | 0.050 |
Why?
|
| Accelerometry | 1 | 2022 | 59 | 0.050 |
Why?
|
| Exercise | 1 | 2007 | 814 | 0.050 |
Why?
|
| Time Factors | 2 | 2024 | 6223 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2009 | 2854 | 0.040 |
Why?
|
| Child, Preschool | 4 | 2022 | 13918 | 0.040 |
Why?
|
| Islets of Langerhans | 1 | 2021 | 173 | 0.040 |
Why?
|
| Diet | 1 | 2007 | 1136 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 5056 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2021 | 6030 | 0.040 |
Why?
|
| Dyslipidemias | 1 | 2021 | 228 | 0.040 |
Why?
|
| Sex Hormone-Binding Globulin | 1 | 2018 | 38 | 0.040 |
Why?
|
| Aspartate Aminotransferases | 1 | 2018 | 79 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2020 | 671 | 0.040 |
Why?
|
| Machine Learning | 1 | 2020 | 220 | 0.040 |
Why?
|
| Electrocardiography | 1 | 2022 | 958 | 0.030 |
Why?
|
| Morbidity | 1 | 2017 | 241 | 0.030 |
Why?
|
| Pediatric Obesity | 1 | 2021 | 384 | 0.030 |
Why?
|
| Androgens | 1 | 2018 | 274 | 0.030 |
Why?
|
| Injections, Subcutaneous | 1 | 2016 | 126 | 0.030 |
Why?
|
| Estradiol | 1 | 2018 | 544 | 0.030 |
Why?
|
| Prevalence | 2 | 2015 | 2409 | 0.030 |
Why?
|
| Life Style | 1 | 2018 | 406 | 0.030 |
Why?
|
| Binge-Eating Disorder | 1 | 2015 | 5 | 0.030 |
Why?
|
| Random Allocation | 1 | 2016 | 433 | 0.030 |
Why?
|
| Drug Delivery Systems | 1 | 2016 | 182 | 0.030 |
Why?
|
| Glomerular Filtration Rate | 1 | 2017 | 482 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2018 | 1142 | 0.030 |
Why?
|
| Ventricular Dysfunction | 1 | 2014 | 24 | 0.030 |
Why?
|
| Atrial Function, Left | 1 | 2014 | 27 | 0.030 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2014 | 106 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2016 | 865 | 0.030 |
Why?
|
| Testosterone | 1 | 2018 | 532 | 0.030 |
Why?
|
| Survival Rate | 1 | 2017 | 2002 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 1689 | 0.020 |
Why?
|
| Disease Progression | 1 | 2017 | 2030 | 0.020 |
Why?
|
| Age Factors | 2 | 2011 | 2811 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 2019 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2021 | 16068 | 0.020 |
Why?
|
| Body Weight | 1 | 2015 | 1007 | 0.020 |
Why?
|
| Gastrointestinal Hormones | 1 | 2010 | 21 | 0.020 |
Why?
|
| Prognosis | 1 | 2020 | 4511 | 0.020 |
Why?
|
| Gastric Bypass | 1 | 2010 | 70 | 0.020 |
Why?
|
| Daunorubicin | 1 | 2009 | 27 | 0.020 |
Why?
|
| Asparaginase | 1 | 2009 | 41 | 0.020 |
Why?
|
| Fatty Liver | 1 | 2010 | 178 | 0.020 |
Why?
|
| Bariatric Surgery | 1 | 2010 | 116 | 0.020 |
Why?
|
| Prednisone | 1 | 2009 | 274 | 0.020 |
Why?
|
| Echocardiography | 1 | 2014 | 1049 | 0.020 |
Why?
|
| Vincristine | 1 | 2009 | 196 | 0.020 |
Why?
|
| Remission Induction | 1 | 2008 | 299 | 0.020 |
Why?
|
| Dexamethasone | 1 | 2009 | 271 | 0.020 |
Why?
|
| Sex Factors | 1 | 2011 | 1265 | 0.020 |
Why?
|
| Physical Endurance | 1 | 2007 | 45 | 0.020 |
Why?
|
| Adolescent Behavior | 1 | 2009 | 171 | 0.020 |
Why?
|
| Middle Aged | 2 | 2021 | 26087 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2015 | 12169 | 0.020 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2010 | 203 | 0.020 |
Why?
|
| Muscle Strength | 1 | 2007 | 75 | 0.020 |
Why?
|
| Texas | 2 | 2007 | 3557 | 0.020 |
Why?
|
| Community Health Services | 1 | 2007 | 88 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2010 | 475 | 0.020 |
Why?
|
| Maternal Behavior | 1 | 2007 | 66 | 0.020 |
Why?
|
| Alkaline Phosphatase | 1 | 2006 | 98 | 0.020 |
Why?
|
| Calcitriol | 1 | 2006 | 81 | 0.020 |
Why?
|
| Magnesium | 1 | 2006 | 121 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 2009 | 378 | 0.020 |
Why?
|
| Hypertension | 1 | 2015 | 1284 | 0.020 |
Why?
|
| Urban Population | 1 | 2007 | 220 | 0.020 |
Why?
|
| Bone Density Conservation Agents | 1 | 2006 | 52 | 0.020 |
Why?
|
| Family Health | 1 | 2007 | 259 | 0.020 |
Why?
|
| Health Education | 1 | 2007 | 225 | 0.020 |
Why?
|
| Minority Groups | 1 | 2007 | 249 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2007 | 448 | 0.020 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2010 | 389 | 0.020 |
Why?
|
| Bone and Bones | 1 | 2006 | 263 | 0.010 |
Why?
|
| Radiography | 1 | 2006 | 822 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2009 | 983 | 0.010 |
Why?
|
| Nuclear Family | 1 | 2003 | 50 | 0.010 |
Why?
|
| Aged | 1 | 2021 | 19195 | 0.010 |
Why?
|
| Mental Disorders | 1 | 2010 | 818 | 0.010 |
Why?
|
| Psychometrics | 1 | 2007 | 664 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2009 | 1118 | 0.010 |
Why?
|
| Medical Records | 1 | 2003 | 190 | 0.010 |
Why?
|
| Calcium | 1 | 2006 | 1098 | 0.010 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2007 | 827 | 0.010 |
Why?
|
| Infant, Premature | 1 | 2006 | 807 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2009 | 1663 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2010 | 3020 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2003 | 1878 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2007 | 3676 | 0.010 |
Why?
|
| Pregnancy | 1 | 2006 | 7129 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2006 | 8114 | 0.010 |
Why?
|